Commission Regulation (EU) 2019/89 of 18 January 2019 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bromadiolone, etofenprox, paclobutrazol and penconazole in or on certain products (Text with EEA relevance.)

Original version: <a href='/vid/commission-regulation-eu-2019-843398958'>Commission Regulation (EU) 2019/89 of 18 January 2019 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bromadiolone, etofenprox, paclobutrazol and penconazole in or on certain products (Text with EEA relevance.)</a>

Linked as:

Legal Act History

Versión futura:
A partir de 13/02/2019
Versión actual:
From

Document options

Extract

Commission Regulation (EU) 2019/89 of 18 January 2019 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bromadiolone, etofenprox, paclobutrazol and penconazole in or on certain products (Text with EEA relevance.)

No longer available (Autolink)

See the full content of this document

This document cites

Treaty establishing the European Community